Heng Fai Ambrose Chan - Mar 31, 2025 Form SCHEDULE 13D Schedule Report for IMPACT BIOMEDICAL INC.

Filing Manager
Chan Heng Fai Ambrose
Reporting Manager
Heng Fai Ambrose Chan
Shares outstanding
12.1M shares
Disclosed Ownership
2.04M shares
Ownership
16.9%
Form type
SCHEDULE 13D
Date filed
4/2/2025, 09:55 PM
Date of event
Mar 31, 2025
Next filing
Apr 4, 2025

Reporting Managers (4)